The activation of p38 MAPK can promote the proliferation of T lymphocytes in mice

Zhe YU,Fei-yue XING,Tong WANG
DOI: https://doi.org/10.3969/j.issn.1001-2478.2007.03.002
2007-01-01
Abstract:To investigate the effect of p38 mitogen-activated protein kinase(MAPK)on the proliferation of T lymphocytes in mice.The effect of a specific inhibitor for p38 MAPK,SB253580,and of an activator for p38 MAPK,anisomycin,on T cell proliferation induced by ConA,were estimated by vital dye carboxyl fluorescin diacetate succinmidyl ester(CFSE)labe- ling technique combined with flow cytometry.At the same time,the correlative proliferation index was measured.The pro- pidium iodide labeling technique was applied to assess the effect of different doses of SB253580 and anisomycin on changes of the T lymphocyte cell-cycle stimulated by ConA or by phorbol ester(PDB)plus lonomycin(Ion).As demonstrated by CFSE staining,the inhibitory effect of a dosage of 0.5~15.0μmol/L SB253580 on ConA-induced T cell proliferation was definite, appearing a dose-dependent manner(r=-0.97,P<0.01).The analysis of the cell-cycle distribution revealed that SB253580 blocked S or G2/M phase entry stimulated by ConA or by PDB plus Ion in a dose-dependent manner(r_s=-0.98,P<0.01; r_(G2/M)=-0.97,P<0.01).The promoting effect of ConA on T cell proliferation was enhanced under the dose of anisomycin from 0.01ng/ml to 0.5ng/ml.With the above dose,anisomycin could promote ConA-induced G2/M phase entry or promote S phase entry stimulated by PDB plus Ion.These results suggest that the activation of p38 MAPK may play an important role in T lymphocyte proliferation stimulated with ConA.
What problem does this paper attempt to address?